|
Volumn 53, Issue 2, 2002, Pages 114-117
|
Transdermal estradiol in menopausal women depresses interleukin-6 without affecting other markers of immune response
|
Author keywords
Growth hormone; Hormone replacement therapy; IGF I; Interleukins; Prolactin; T cell proliferation
|
Indexed keywords
CYTOKINE;
ESTRADIOL;
GROWTH HORMONE;
INTERLEUKIN 10;
INTERLEUKIN 2;
INTERLEUKIN 6;
PROLACTIN;
SOMATOMEDIN C;
ADULT;
AGE;
ARTICLE;
CELL PROLIFERATION;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFECT;
ENZYME ASSAY;
ESTROGEN THERAPY;
FEMALE;
HORMONE DETERMINATION;
HORMONE SUBSTITUTION;
HUMAN;
IMMUNE RESPONSE;
IMMUNITY;
MENOPAUSE;
MITOGENESIS;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
PROTEIN DETERMINATION;
T LYMPHOCYTE;
ADMINISTRATION, CUTANEOUS;
ESTRADIOL;
ESTROGEN REPLACEMENT THERAPY;
FEMALE;
HUMANS;
INTERLEUKIN-6;
LYMPHOCYTE ACTIVATION;
MENOPAUSE;
MIDDLE AGED;
T-LYMPHOCYTES;
|
EID: 0036230480
PISSN: 03787346
EISSN: None
Source Type: Journal
DOI: 10.1159/000053005 Document Type: Article |
Times cited : (48)
|
References (19)
|